The story has been updated to include comments from a conference call this morning.

NEW YORK (GenomeWeb News) – GenMark Diagnostic's third-quarter revenues increased four-fold year over year, the Carlsbad, Calif.-based molecular diagnostics firm reported after the close of the market on Wednesday.

For the three months ended Sept. 30, revenues rose to $5.3 million from $1.3 million, with product revenues reaching $5.2 million, compared to $1.2 million a year ago. Licensing and other revenues fell to $62,000 from $110,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.